CAS RN: 1818393-16-6

AA-115 (APG-115)

Product Availability

Choose a grade to view its available package options.

12 package records11 with current stock2 grade groups
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20260523 100mg In stock Shanghai Inquiry
Batchno.20250916 10mg In stock Shanghai Inquiry
Batchno.20260521 10mg / 25mg / 50mg Out of stock 8-10 business days Inquiry
Batchno.20251019 1mg In stock Shanghai Inquiry
Batchno.20250503 250mg In stock Shanghai Inquiry
Batchno.20260127 25mg In stock Shanghai Inquiry
Batchno.20250915 50mg In stock Shanghai Inquiry
Batchno.20260608 5mg In stock Shanghai Inquiry
Batch No.PackageAvailabilityWarehouseLead TimeInquiry
Batchno.20250925 100mg In stock Inquiry
Batchno.20260121 1mg In stock Inquiry
Batchno.20250725 25mg In stock Inquiry
Batchno.20260328 5mg In stock Inquiry
  • Product code: starshine_CAS1818393-16-6
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

1818393-16-6 / AA-115 (APG-115)

Standard CAS: 1818393-16-6 Multi CAS: No

Basic Information

CAS
1818393-16-6
Multi CAS
No
Molecular Formula
C34H38Cl2FN3O4
Molecular Weight
642.600000
Exact Mass
641.222340
SMILES
CCN1[C@H]([C@@H]([C@]2(C13CCCCC3)C4=C(C=C(C=C4)Cl)NC2=O)C5=C(C(=CC=C5)Cl)F)C(=O)NC67CCC(CC6)(CC7)C(=O)O
InChI
InChI=1S/C34H38Cl2FN3O4/c1-2-40-27(28(41)39-32-16-13-31(14-17-32,15-18-32)30(43)44)25(21-7-6-8-23(36)26(21)37)34(33(40)11-4-3-5-12-33)22-10-9-20(35)19-24(22)38-29(34)42/h6-10,19,25,27H,2-5,11-18H2,1H3,(H,38,42)(H,39,41)(H,43,44)/t25-,27+,31?,32?,34+/m0/s1
InChIKey
YJCZPJQGFSSFOL-MNZPCBJKSA-N

Computed Properties

Structural Parameters

Heavy atom count
44
Aromatic heavy atom count
12
Fraction Csp3
0.56
Rotatable bonds
5
H-bond acceptors
4
H-bond donors
3
Molar refractivity
166.54
TPSA
98.74

LogP / Solubility

WLOGP
6.81
MLOGP
6.04
XLogP3
3.6
Consensus LogP
5.48
Log S (ESOL)
-7.98
Class (ESOL)
Insoluble
Log S (Ali)
-9.74
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-10.09
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-1.81

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
10

Safety & Transport

GHS Hazard Statements
Not Classified Reported as not meeting GHS hazard criteria by 1 of 1 companies. For more detailed information, please visit ECHA C&L website.

Get In Touch

Contact Us